🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

24 recruiting trials

for Malignant Oral Cavity Neoplasm

Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors NCT04879121Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Larotrectinib Sulfate A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) NCT05865002Phase 137 sites📍 Vijayawada📍 Visakhapatnam📍 Chandigarh Aurigene Discovery Technologies Limited · Tests: AUR107 Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore NCT03975322n/a1 site📍 Erlangen University of Erlangen-Nürnberg Medical School Physiologic MR Imaging of Salivary Gland Tumors NCT04452162NA1 site📍 Philadelphia Abramson Cancer Center at Penn Medicine · Tests: MRI Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population NCT06997068Phase 21 site📍 Rochester Mayo Clinic · Tests: Celecoxib, Erlotinib Hydrochloride, Imaging Procedure, Interview, Methotrexate RAPA-201 Therapy of Solid Tumors NCT05144698Phase 1, Phase 21 site📍 Hackensack Rapa Therapeutics LLC · Tests: RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior to RAPA-201 Therapy, Pembrolizumab (PD-1 Blocking Antibody) Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases NCT03093909Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Gemcitabine Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery NCT01269190NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: High-Resolution Microendoscopy, Multispectral Imaging, Proflavine Validation of the O-bridge Protocol: a Prospective, Multicenter Trial NCT04007783n/a5 sites📍 Antwerp📍 Antwerp📍 Bruges AZ Sint-Jan AV Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" NCT01365169NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Exercise Intervention, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors NCT04068155NA2 sites📍 Grenoble📍 Lyon Alpha Tau Medical LTD. · Tests: DaRT- Diffusing Alpha-emitters Radiation Therapy SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography NCT06321003n/a1 site📍 Palermo University of Palermo · Tests: OCT (Optical Coherence Tomography) Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors NCT04265430Phase 41 site📍 Houston M.D. Anderson Cancer Center · Tests: Contrast Agent, Magnetic Resonance Imaging, Quality-of-Life Assessment, Questionnaire Administration High-Resolution PET-CT Imaging for Surgical Margin Visualization NCT06915454NA1 site📍 Nashville Vanderbilt-Ingram Cancer Center · Tests: Intra-op PET/CT Specimen Scanner A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites📍 Aurora📍 Lake Mary📍 Lebanon 7 Hills Pharma, LLC · Tests: Alintegimod, Ipilimumab, Nivolumab Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. NCT03889899NA1 site📍 Haifa Alpha Tau Medical LTD. · Tests: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment NCT06279013NA34 sites📍 Phoenix📍 Little Rock📍 Albany NRG Oncology · Tests: Counseling, Health Education, Interview, Medical Chart Review, Monitoring The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study NCT06535867n/a1 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: mHealth Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck NCT01473784NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: transoral robotic surgery, quality of life assessment Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD) NCT05296941NA1 site📍 Falun Dalarna County Council, Sweden · Tests: Brush sampling Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia NCT04534127NA1 site📍 Jerusalem Alpha Tau Medical LTD. · Tests: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment NCT04622462n/a3 sites📍 Edmonton📍 Edmonton📍 London Proteocyte Diagnostics Inc. · Tests: Standard of Care Histopathology, STRATICYTE Assessment Rate of Malignant Transformation and Clinical Characteristics Among an Oral Lichen Planus Cohort: a Retrospective Center Experience NCT06934863n/a1 site📍 Roma Catholic University of the Sacred Heart A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) NCT06655246Phase 132 sites📍 Birmingham📍 Phoenix📍 La Jolla Kura Oncology, Inc. · Tests: ziftomenib, imatinib mesylate
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy